Skip to main content
. 2019 Aug 7;8(8):1183. doi: 10.3390/jcm8081183

Table 4.

Concordant PIK3CA and TP53 somatic mutations between tumors and ctDNA in primary breast cancer patients.

Patient ID Diagnostic Mammography Markers Type Gene HGVS SafeSEQ VAF (%) Protein Tumor VAF (%) COSMIC Chr
13MS IDC, grade 3 ER+/HER2+ Luminal B TP53 c.398T > A 20.56 p.M133K 75.2 COSM11781 17
16MS IDC, grade 3 ER+/HER2+ Luminal B PIK3CA c.3140A > T 3.60 p.H1047L 28.2 COSM776 3
16MS IDC, grade 3 ER+/HER2+ Luminal B TP53 c.743G > T 2.11 p.R248L 43.1 COSM6549 17
44MS IDC, grade 3 ER+/HER2+ Luminal B TP53 c.587G > C 1.03 p.R196P 35.8 COSM43814 17
9MS IDC, grade 3 ER-/PR-/HER2- Triple negative TP53 c.637C > T 0.91 p.R213Ter 46.9 COSM10654 17
67MS IDC, grade 2 ER+/HER2− Luminal A PIK3CA c.3145G > C 0.39 p.G1049R 82.4 COSM12597 3
7MS IDC, grade 2 ER+/HER2− Luminal A PIK3CA c.3140A > G 0.14 p.H1047R 31 COSM775 3
30MS IDC, grade 2 ER+/HER2− Luminal A PIK3CA c.1633G > A 0.05 p.E545K 56.2 COSM763 3
40MS IDC, grade 1 ER+/HER2+ Luminal B PIK3CA c.1624G > A 0.20 p.E542K 25.5 COSM760 3

IDC: Invasive ductal carcinoma; HGVS: Human Genome Variation Society; SafeSEQ VAF: Plasma variant allele frequency; Tumor VAF: Tumor variant allele frequency; COSMIC: Catalog of somatic mutations in cancer; Chr: Chromosome.